ArticleTherapeutic advances in hematology2024
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis.
Tim Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it